The Washington Post continues losing its subscribers after the newspaper editors and owner Jeff Bezos decided not to endorse former Democratic presidential nominee Kamala Harris.
Semafor reported that traffic to the Post’s website had tanked over the last four years. According to internal data discovered by the news source recently, the newspaper’s regular 2024 daily traffic sunk to less than a quarter of its peak in January 2021, when the Post reached approximately 22.5 million people using the website daily. However, by the middle of 2024, only about 2.5-3 million people were using the website daily.
In April 2024, Washington City Paper wrote that the newspaper stopped publicly disclosing its traffic numbers in press releases after discovering a 60% decline in monthly traffic.
The Wall Street Journal also recently reported that the Post’s revenue fell from $190 million in 2023 to $174 million in 2024.
Headline USA also pointed out that after almost losing $77 million in 2024, the newspaper started firing people, resulting in 4% of the Post’s employees losing their jobs. […]
— Read More: headlineusa.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.
